EKR Therapeutics Appoints Dr. Tong Zhang as Director of Business Development, Further Positioning the Company for Long-term Growth

CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, acquiring, and commercializing supportive care prescription products to enhance the quality-of-life for cancer patients, today announced the appointment of Tong Zhang, Ph.D. to the newly created position of Director of Business Development.

MORE ON THIS TOPIC